Moreover, ARHI re-expression reversed JMJD2A-induced tumor progression in vitro (Figure 7) and in vivo (Figure 8), which in turn corroborated our results that JMJD2A promotes breast cancer progression through transcriptional repression of the tumor suppressor ARHI. This evidence concerns the gene DIRAS3 and breast carcinoma.